Yasir Hassan

20+ years in healthcare and life sciences, with two successful company exits: Health iQ and CorEvitas, the latter sold to Thermo Fisher for $1bn, where I was Chief Product Officer and sat on the board through the M&A process. I’ve since built a portfolio of board and advisory roles spanning med-tech (SurgEase Medical), venture (Y-Innovations, ReeWire Ventures), corporate finance (Vesselbridge Capital) and commercial strategy (Sciensus, Beaufort Advisory).
I know how to take a health-tech or biotech company from early-stage product to scaled commercial business, and increasingly that means opening up new geographies. Through Y-Innovations and Beaufort Advisory I’ve built a strong network across the Middle East, and I help companies navigate licensing, market entry and funding routes into Saudi Arabia and the wider Gulf - a region most Western health-tech and biotech companies underestimate and under-resource.
Best fit: health-tech and biotech companies at seed-to-growth stage needing help with commercial strategy, market access or fundraising; med-tech companies scaling into new markets or geographies; and any company looking to license or expand into the Middle East, where my network and experience can shortcut a process most companies get wrong the first time.